Nuwellis Inc (NUWE) Stock Price, Quote & News

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and...

Industry: Medical Devices

Sector: Healthcare

Phone: 952 345 4200

Website: www.nuwellis.com

Address:

12988 Valley View Road, Eden Prairie, United States

NUWE_to_the_moon Nov. 14 at 10:17 PM

$NUWE Hopefully all the paper handed btches sold yesterday and now we can shoot back up.

0 · Reply

NUWE_to_the_moon Nov. 14 at 9:07 PM

$NUWE

0 · Reply

Jacks10 Nov. 14 at 9:00 PM

$NUWE Well, this market is completely nuts, up 11% now after being killed the last week, some Cannabis down 20% because people don't understand what they read and panic, and other stocks filing lawsuits and getting halted for short seller manipulation, may the 1000% runners start on Monday.

0 · Reply

makedatbread88 Nov. 14 at 8:55 PM

$NUWE adding here into the close oversold low floater

0 · Reply

MCapitalJ Nov. 14 at 7:29 PM

$NUWE 👀 I want you next. Looking for a 10x here, $25PPS

1 · Reply

GoodTidings Nov. 14 at 1:46 PM

$ICU The 2 months of silence makes sense now... They couldn't report anything positive which says a lot... The fact that in the first 6 weeks of Q4 are more orders than in Q3 is nice but it doesn't compensate for the required sales needed to prevent dilution or a R/S... The FDA registration burden also doesn't help... There is no guarantee it will be scrapped and only relying on hope didn't do well in the past with this company... Especially with the incompetence of management... They don't look ahead but only in the mirror... Recipe for disaster... This company appears imo to walk into a kamikaze failure... Or it is a $NUWE 2.0 R/S each 2 year and wreck havoc on investors...

1 · Reply

bazooka007 Nov. 13 at 7:14 PM

$NUWE volume 27 k and 10% down. That is exactly my kind of humor.

0 · Reply

done84 Nov. 13 at 5:12 PM

$NUWE where are the pumpers with their stupid $40 PT's? 😂😂 Scam. 🖕🖕🖕

0 · Reply

done84 Nov. 13 at 4:33 PM

$NUWE Robbed so much money from investors. 🖕🖕🖕

0 · Reply

NUWE_to_the_moon Nov. 13 at 3:59 PM

$NUWE i think buyers in $NVVE +260% meant to jump into $NUWE come on over!

0 · Reply

Nuwellis, Inc. (NUWE) Q3 2025 Earnings Call Prepared Remarks Transcript

Nov 12, 2025, 8:15 AM EST - 2 days ago

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nov 10, 2025, 9:00 AM EST - 4 days ago

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Oct 23, 2025, 9:00 AM EDT - 22 days ago

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Sep 30, 2025, 8:45 AM EDT - 6 weeks ago

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Sep 18, 2025, 9:00 AM EDT - 2 months ago

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Sep 17, 2025, 10:16 AM EDT - 2 months ago

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Sep 9, 2025, 9:00 AM EDT - 2 months ago

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Sep 4, 2025, 8:15 AM EDT - 2 months ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Aug 21, 2025, 8:15 AM EDT - 3 months ago

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Aug 19, 2025, 8:15 AM EDT - 3 months ago

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Aug 15, 2025, 8:15 AM EDT - 3 months ago

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 14, 2025, 2:37 PM EDT - 3 months ago

Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 8:15 AM EDT - 3 months ago

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 7, 2025, 8:15 AM EDT - 3 months ago

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Aug 6, 2025, 8:15 AM EDT - 3 months ago

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Aug 5, 2025, 8:15 AM EDT - 3 months ago

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Aug 4, 2025, 5:24 PM EDT - 3 months ago

Nuwellis Stockholders Approve All Proposals at Special Meeting

Jul 23, 2025, 8:45 AM EDT - 4 months ago

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 23, 2025, 8:15 AM EDT - 4 months ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Jul 22, 2025, 8:15 AM EDT - 4 months ago

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 17, 2025, 7:35 AM EDT - 4 months ago

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Jul 15, 2025, 4:05 PM EDT - 4 months ago

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Jul 2, 2025, 8:15 AM EDT - 4 months ago

Nuwellis Appoints John Erb as Chief Executive Officer

Jun 10, 2025, 4:15 PM EDT - 5 months ago

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Jun 9, 2025, 9:15 AM EDT - 5 months ago

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

May 13, 2025, 10:50 AM EDT - 6 months ago

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

May 13, 2025, 7:00 AM EDT - 6 months ago

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 12, 2025, 7:00 AM EDT - 6 months ago

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 8, 2025, 7:00 AM EDT - 6 months ago

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

Apr 24, 2025, 7:00 AM EDT - 7 months ago

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Apr 22, 2025, 4:05 PM EDT - 7 months ago

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Mar 11, 2025, 12:23 PM EDT - 8 months ago

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 8:00 AM EDT - 8 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 24, 2025, 4:05 PM EST - 9 months ago

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

Feb 20, 2025, 8:00 AM EST - 9 months ago

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Feb 18, 2025, 4:15 PM EST - 9 months ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Nov 11, 2024, 11:02 AM EST - 1 year ago

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 8:00 AM EST - 1 year ago

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nov 5, 2024, 9:28 AM EST - 1 year ago

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nov 4, 2024, 8:30 AM EST - 1 year ago

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nov 1, 2024, 4:15 PM EDT - 1 year ago

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer

Oct 23, 2024, 4:15 PM EDT - 1 year ago

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

Sep 25, 2024, 4:15 PM EDT - 1 year ago

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

Aug 23, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Aug 13, 2024, 12:39 PM EDT - 1 year ago

Nuwellis, Inc. (NUWE) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

Jul 26, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE™ Therapy at Cincinnati Children's

Jul 24, 2024, 8:02 AM EDT - 1 year ago

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

NUWE_to_the_moon Nov. 14 at 10:17 PM

$NUWE Hopefully all the paper handed btches sold yesterday and now we can shoot back up.

0 · Reply

NUWE_to_the_moon Nov. 14 at 9:07 PM

$NUWE

0 · Reply

Jacks10 Nov. 14 at 9:00 PM

0 · Reply

makedatbread88 Nov. 14 at 8:55 PM

$NUWE adding here into the close oversold low floater

0 · Reply

MCapitalJ Nov. 14 at 7:29 PM

$NUWE 👀 I want you next. Looking for a 10x here, $25PPS

1 · Reply

GoodTidings Nov. 14 at 1:46 PM

1 · Reply

bazooka007 Nov. 13 at 7:14 PM

$NUWE volume 27 k and 10% down. That is exactly my kind of humor.

0 · Reply

done84 Nov. 13 at 5:12 PM

$NUWE where are the pumpers with their stupid $40 PT's? 😂😂 Scam. 🖕🖕🖕

0 · Reply

done84 Nov. 13 at 4:33 PM

$NUWE Robbed so much money from investors. 🖕🖕🖕

0 · Reply

NUWE_to_the_moon Nov. 13 at 3:59 PM

$NUWE i think buyers in $NVVE +260% meant to jump into $NUWE come on over!

0 · Reply

bazooka007 Nov. 13 at 3:52 PM

$NUWE every day the same shitshow. Hardly any volume and down down down. I wont sell, fu.

0 · Reply

Russell007xx Nov. 13 at 12:58 PM

$NUWE like I said, a junk is always junk. Expecting Under 1 by the end of the year and then perhaps another RS

1 · Reply

Notorious_Johnny_V Nov. 13 at 3:16 AM

$NUWE the earnings report was very disappointing to say the least. However things may be looking up here with the $3M NIH grant for the company's development partner and strong clinical results. As long as they don't dilute we should be over $3 at some point in the next few months IMO. Totally off topic but $ROMJF released Q3 earnings tonight and they were very impressive for a 37 cent stock 👀

0 · Reply

StocktwitsEarnings Nov. 12 at 7:37 PM

$NUWE Q3 '25 Earnings Results & Recap Nuwellis reported Q3 2025 revenue of $2.2 million, a 6% decrease year-over-year, and a net income attributable to common shareholders was $469,000, or $0.56 per share.

0 · Reply

Dominicstocks Nov. 12 at 5:53 PM

$NUWE Well back to 25 cents for 30 days Get another nasdaq notice of being under 1 dollar for longer than 30 days Then they will do another reverse split Worse than the one they just did Or dilute the stock with more shares Either way I’m never getting my money back

2 · Reply

Russell007xx Nov. 12 at 2:13 PM

$NUWE scammers running this company

0 · Reply

bazooka007 Nov. 12 at 2:10 PM

$NUWE

0 · Reply

NUWE_to_the_moon Nov. 12 at 2:06 PM

$NUWE

0 · Reply